Lexpos News

Following on from our update about antibiotic supply and pricing issues on Friday 9th December, we wanted to share some recent developments. HDA statement The Healthcare Distribution Association (HDA), whose member companies distribute over 90% of prescription medicines on behalf of the NHS, has issued a lengthy statement regarding the availability of Strep A treatments. [...]

The post Antibiotic supply and pricing issues: Steps taken this week appeared first on PSNC Website.

Update (30/01/2023) – Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of all Co-beneldopa capsules and tablets. In December 2022, PSNC advised that the special container rules apply to all branded or generically written prescriptions for Madopar® dispensed from December 2022 onwards (except for generically prescribed Co-beneldopa 12.5mg/50mg [...]

The post Co-beneldopa (including Madopar®) preparations re-classified as special containers appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Antibiotics for the treatment of Group A Strep. MSN/2022/105 Tier 2 – medium impact Date of issue 12th December 2022 Supplies of antibiotics for the treatment of Group A Strep have seen a surge in demand and may be temporarily in [...]

The post Medicine Supply Notification: Antibiotics for the treatment of Group A Strep appeared first on PSNC Website.

NHS England and PSNC have agreed that contractors will only have to participate in one mandatory national health campaign for 2022/23 (pharmacies can be required to participate in up to six health campaigns at the request of NHS England per year). This campaign will be on weight management and will start on Tuesday 3rd January [...]

The post Mandatory weight management campaign in January appeared first on PSNC Website.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 5 December 2022) has been published and includes articles on: Valproate: reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months COVID-19 vaccines and medicines: updates for December 2022 Letters and [...]

The post MHRA Drug Safety Update December 2022 appeared first on PSNC Website.